The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $80.78

Today's change+0.37 +0.46%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.
 

Express Scripts Holding Co

Nasdaq: ESRX
Last

(U.S.) $80.78

Today's change+0.37 +0.46%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.

Express Scripts Holding Co up (U.S.)$0.37

Express Scripts Holding Co closed up Wednesday by (U.S.)$0.37 or 0.46% to (U.S.)$80.78. Over the last five days, shares have gained 0.54% and are currently 1.19% off of the 52-week high. Over the last year, this stock has underperformed the S&P 500, gaining 10.42% vs. the index's 23.58%.

Key company metrics

  • Open(U.S.) $80.97
  • Previous close(U.S.) $80.41
  • High(U.S.) $81.03
  • Low(U.S.) $80.45
  • Bid / Ask(U.S.) $76.83 / (U.S.) $85.62
  • YTD % change+8.23%
  • Volume3,261,657
  • Average volume (10-day)3,998,966
  • Average volume (1-month)4,172,449
  • Average volume (3-month)4,017,590
  • 52-week range(U.S.) $55.80 to (U.S.) $81.76
  • Beta0.94
  • Trailing P/E13.30×
  • P/E 1 year forward11.50×
  • Forward PEG0.91×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.08
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.66%

Based on its net profit margin of 3.66%, Express Scripts Holding Co is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.17%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue24,68325,34824,65524,863
Total other revenue--------
Total revenue24,68325,34824,65524,863
Gross profit2,2382,1611,8732,338
Total cost of revenue22,44623,18622,78222,525
Total operating expense23,20523,96923,60023,389
Selling / general / administrative759783818864
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income1,4781,3791,0551,475
Interest income (expense), net non-operating-148-147-146-146
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3441,2419151,335
Income after tax8458065501,440
Income tax, total499435365-104
Net income8428025461,435
Total adjustments to net income--------
Net income before extra. items8428025461,435
Minority interest-3-4-4-5
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8428025461,435
Inc. avail. to common incl. extra. items8428025461,435
Diluted net income8428025461,435
Dilution adjustment--------
Diluted weighted average shares575586605613
Diluted EPS excluding extraordinary itemsvalue per share1.461.370.902.34
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.461.370.902.34